SMILE proved effective in correcting residual myopia and myopic astigmatism in pseudophakic eyes, leading to significant visual acuity gain.
In a poster presented at the American Academy of Ophthalmology meeting, Anita Syla Lokaj, MD, PhD, and co-authors showed the results of a retrospective study of patients from Kosovo and other countries.
“Aim of this study is to improve visual acuity in pseudophakic patients who have residual myopic refraction after 3 months of surgery,” using the SMILE module from the VisuMax femtosecond laser (Carl Zeiss Meditec), they wrote.
A total of 280